Metabolic causal factor of immune cell function and fate in the tumor microenvironment
Authors:
- 2 March 2026
- journal article
- review article
- Published by Elsevier in Bulletin du Cancer
- Vol. 113 (6) , 777-789
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- CD38-NAD+Axis Regulates Immunotherapeutic Anti-Tumor T Cell ResponseCell Metabolism, 2018
- Foxp3 Reprograms T Cell Metabolism to Function in Low-Glucose, High-Lactate EnvironmentsCell Metabolism, 2017
- PI3Kγ is a molecular switch that controls immune suppressionNature, 2016
- A guide to immunometabolism for immunologistsNature Reviews Immunology, 2016
- IDO in the Tumor Microenvironment: Inflammation, Counter-Regulation, and ToleranceTrends in Immunology, 2016
- Cancer mediates effector T cell dysfunction by targeting microRNAs and EZH2 via glycolysis restrictionNature Immunology, 2015
- Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer ProgressionCell, 2015
- PD-1 alters T-cell metabolic reprogramming by inhibiting glycolysis and promoting lipolysis and fatty acid oxidationNature Communications, 2015
- Network Integration of Parallel Metabolic and Transcriptional Data Reveals Metabolic Modules that Regulate Macrophage PolarizationImmunity, 2015
- The Transcription Factor Myc Controls Metabolic Reprogramming upon T Lymphocyte ActivationImmunity, 2011